News for the Multiple Sclerosis Community

Double Dose Copaxone Shows Efficacy At 3 Months

I hadn't seen these results of double-dose Copaxone posted before, but in this patent application, Teva is stating that "Also observed was the accelerated rate at which the 40 mg/day dose became effective as compared to the 20 mg/day dose. This was unexpected. Specifically, the 40 mg/day dose showed efficacy, as measured by MRI, by the third month, whereas the 20 mg/day dose did not show efficacy until the sixth month."

Previous 9 month results had not seemed as interesting.